BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6404440)

  • 1. Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial.
    Coutinho RA; Lelie N; Albrecht-Van Lent P; Reerink-Brongers EE; Stoutjesdijk L; Dees P; Nivard J; Huisman J; Reesink HW
    Br Med J (Clin Res Ed); 1983 Apr; 286(6374):1305-8. PubMed ID: 6404440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy trial of heat-inactivated hepatitis B vaccine (CLB) in male homosexuals in the Netherlands.
    Coutinho RA; Lelie PN; Albrecht-van Lent P; Stoutjesdijk L; Huisman J; Kuipers H; Schut LJ; Reerink-Brongers EE; Reesink HW; van Aken WG
    Dev Biol Stand; 1983; 54():287-92. PubMed ID: 6228469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report.
    Szmuness W; Stevens CE; Zang EA; Harley EJ; Kellner A
    Hepatology; 1981; 1(5):377-85. PubMed ID: 7030902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial.
    Desmyter J; Colaert J; De Groote G; Reynders M; Reerink-Brongers EE; Lelie PN; Dees PJ; Reesink HW
    Lancet; 1983 Dec; 2(8363):1323-8. PubMed ID: 6139668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men.
    Francis DP; Hadler SC; Thompson SE; Maynard JE; Ostrow DG; Altman N; Braff EH; O'Malley P; Hawkins D; Judson FN; Penley K; Nylund T; Christie G; Meyers F; Moore JN; Gardner A; Doto IL; Miller JH; Reynolds GH; Murphy BL; Schable CA; Clark BT; Curran JW; Redeker AG
    Ann Intern Med; 1982 Sep; 97(3):362-6. PubMed ID: 6810736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.
    Szmuness W; Stevens CE; Harley EJ; Zang EA; Oleszko WR; William DC; Sadovsky R; Morrison JM; Kellner A
    N Engl J Med; 1980 Oct; 303(15):833-41. PubMed ID: 6997738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients.
    Crosnier J; Jungers P; Couroucé AM; Laplanche A; Benhamou E; Degos F; Lacour B; Prunet P; Cerisier Y; Guesry P
    Lancet; 1981 Apr; 1(8224):797-800. PubMed ID: 6111671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff.
    Crosnier J; Jungers P; Couroucé AM; Laplanche A; Benhamou E; Degos F; Lacour B; Prunet P; Cerisier Y; Guesry P
    Lancet; 1981 Feb; 1(8218):455-9. PubMed ID: 6110088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale efficacy trials of hepatitis B vaccines in the USA: baseline data and protocols.
    Szmuness W
    J Med Virol; 1979; 4(4):327-40. PubMed ID: 541683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B in haemodialysis: vaccination against HBS antigen.
    Crosnier J
    Proc Eur Dial Transplant Assoc; 1981; 18():231-40. PubMed ID: 7036150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal).
    Maupas P; Chiron JP; Barin F; Coursaget P; Goudeau A; Perrin J; Denis F; Mar ID
    Lancet; 1981 Feb; 1(8215):289-92. PubMed ID: 6109938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to a heat-inactivated hepatitis B vaccine in patients undergoing hemodialysis. Enhancement of the response by increasing the dose of hepatitis B surface antigen from 3 to 27 micrograms.
    Lelie PN; Reesink HW; de Jong-van Manen ST; Dees PJ; Reerink-Brongers EE
    Arch Intern Med; 1985 Feb; 145(2):305-9. PubMed ID: 3977491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy.
    Dienstag JL; Werner BG; Polk BF; Snydman DR; Craven DE; Platt R; Crumpacker CS; Ouellet-Hellstrom R; Grady GF
    Ann Intern Med; 1984 Jul; 101(1):34-40. PubMed ID: 6233921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.
    Stevens CE; Alter HJ; Taylor PE; Zang EA; Harley EJ; Szmuness W
    N Engl J Med; 1984 Aug; 311(8):496-501. PubMed ID: 6235453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men.
    Hadler SC; Francis DP; Maynard JE; Thompson SE; Judson FN; Echenberg DF; Ostrow DG; O'Malley PM; Penley KA; Altman NL
    N Engl J Med; 1986 Jul; 315(4):209-14. PubMed ID: 2941687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis B vaccination - before a breakthrough?].
    Grob PJ
    Schweiz Med Wochenschr; 1981 Aug; 111(31-32):1146-53. PubMed ID: 7025194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of long-term efficacy on plasma-derived hepatitis B vaccine].
    Xu H
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Dec; 13(6):362-5. PubMed ID: 1303319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined immunoprophylaxis induces changes in anti-hepatitis B surface protein titer in infants born to mothers with positivity for hepatitis B surface antigen].
    Wang J; Feng YL; Liu MH; Bai Y; Feng DH; Yuan NX; Du DQ; Feng WH; Liu HL; Yang Y; Liu JF; He YL; Song HX; Liu Y; Zhao YR; Chen TY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):580-3. PubMed ID: 24119736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis prophylaxis.
    Aach RD
    Johns Hopkins Med J; 1982 Dec; 151(6):318-25. PubMed ID: 6184517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.